Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie Tetzlaff PhD

Julie Tetzlaff PhD

Associate Dean, Assistant Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration
Program: Pediatrics


Research Experience

  • Autistic Disorder
  • Biomarkers
  • Brain Concussion
  • Drug Approval
  • Drug Evaluation, Preclinical
  • Fragile X Syndrome
  • Hemangioma
  • Neurosciences
  • Parkinson Disease
  • Receptors, Metabotropic Glutamate
  • Sudden Infant Death
  • alpha-Synuclein
  • Methodologies and Techniques

  • Behavioral Research
  • Blotting, Western
  • Cell Culture Techniques
  • Enzyme-Linked Immunosorbent Assay
  • Facial Nerve Injuries
  • Immunohistochemistry
  • Leadership Positions

  • Co-Founder and President elect of the Massachusetts General Hospital Postdoctoral Association (2007-2008)
  • Scientific Coordinator of the WI SIDS Research Center (2011-Present)
  • Assistant Dean of Postdoctoral Education-MCW (2014-Present)
  • Postdoc Industry Consultant (PICO) faculty advisor (2014-Present)
  • Associate Dean for Postdoctoral Affairs and Graduate Career Development (2017-present)
  • MCW Program / Core Facilities

  • CRI Histology Core Laboratory
  • CRI Pediatric Biobank
  • Educational Expertise

  • Neurosciences
  • Community Partnerships

  • Medical Examiner (Milwaukee County)
  • Publications

  • Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion. (Klein AP, Tetzlaff JE, Bonis JM, Nelson LD, Mayer AR, Huber DL, Harezlak J, Mathews VP, Ulmer JL, Sinson GP, Nencka AS, Koch KM, Wu YC, Saykin AJ, DiFiori JP, Giza CC, Goldman J, Guskiewicz KM, Mihalik JP, Duma SM, Rowson S, Brooks A, Broglio SP, McAllister T, McCrea MA, Meier TB) J Neurotrauma 2019 Feb 25 PMID: 30618331 01/09/2019    
  • Dopamine-induced conformational changes in alpha-synuclein. (Outeiro TF, Klucken J, Bercury K, Tetzlaff J, Putcha P, Oliveira LM, Quintas A, McLean PJ, Hyman BT) PLoS One 2009 Sep 04;4(9):e6906 PMID: 19730729 PMCID: PMC2731858 09/05/2009       42 Citations
  • CHIP targets toxic alpha-Synuclein oligomers for degradation. (Tetzlaff JE, Putcha P, Outeiro TF, Ivanov A, Berezovska O, Hyman BT, McLean PJ) J Biol Chem 2008 Jun 27;283(26):17962-8 PMID: 18436529 PMCID: PMC2936239 04/26/2008       99 Citations
  • Formation of toxic oligomeric alpha-synuclein species in living cells. (Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ) PLoS One 2008 Apr 02;3(4):e1867 PMID: 18382657 PMCID: PMC2270899 04/03/2008       245 Citations
  • Cellular localization of androgen and estrogen receptors in mouse-derived motoneuron hybrid cells and mouse facial motoneurons. (Tetzlaff J, Tanzer L, Jones KJ) Dev Neurobiol 2007 Sep 01;67(10):1362-70 PMID: 17638386 07/20/2007       11 Citations
  • Exogenous androgen treatment delays the stress response following hamster facial nerve injury. (Tetzlaff J, Tanzer L, Jones KJ) J Neuroendocrinol 2007 May;19(5):383-9 PMID: 17425613 04/12/2007       16 Citations
  • Motoneuron injury and repair: New perspectives on gonadal steroids as neurotherapeutics. (Tetzlaff JE, Huppenbauer CB, Tanzer L, Alexander TD, Jones KJ) J Mol Neurosci 2006;28(1):53-64 PMID: 16632875 04/25/2006       21 Citations
  • Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine. (Chen Z, Tetzlaff J, Sripathirathan K, Carrasco GA, Shankaran M, Van De Kar LD, Muma NA, Battaglia G) Psychopharmacology (Berl) 2005 Jul;180(2):316-26 PMID: 15864558 05/03/2005       5 Citations
  • Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. (Serpe CJ, Tetzlaff JE, Coers S, Sanders VM, Jones KJ) Brain Behav Immun 2002 Dec;16(6):808-12 PMID: 12480509 12/14/2002       35 Citations
  • Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. (Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD) J Neurosci 2002 Nov 01;22(21):9635-42 PMID: 12417689 11/06/2002       64 Citations
  • Effects of hippocampal injections of a novel ligand selective for the alpha 5 beta 2 gamma 2 subunits of the GABA/benzodiazepine receptor on Pavlovian conditioning. (Bailey DJ, Tetzlaff JE, Cook JM, He X, Helmstetter FJ) Neurobiol Learn Mem 2002 Jul;78(1):1-10 PMID: 12071663 06/20/2002       39 Citations
  • Last update: 01/17/2019
    jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70